Fall Savings30% off everything · Code:
Back
Neuro Research

Pinealon

CAS 175175-23-2Research Use Only

A short synthetic tripeptide bioregulator (Glu-Asp-Arg), studied in the literature for its role in gene-expression regulation and neuronal cell-viability research models. For laboratory research use only.

$60$42WITH CODE FALL
Dosage
Quantity
$60.00
Bundle & save
Free priority shipping on $250+
Third-party tested
U.S.-synthesized & shipped
Discreet packaging
Secure checkoutVisaMastercardAmerican ExpressDiscover

Card fields are hosted by our payment provider, so card numbers are never received or stored by Ventra. Apple Pay, Google Pay and Link are also available at checkout.

Compound Information

Technical specifications

Molecular Profile

What is this compound?

Pinealon is a synthetic tripeptide bioregulator with the Glu-Asp-Arg (EDR) sequence, supplied as a lyophilized powder for in vitro laboratory research use only. It belongs to the Khavinson family of short peptide bioregulators and appears in the peer-reviewed literature in studies of gene expression and protein synthesis regulation, cell-viability research, and free-radical signaling in neuronal research models.

Research applications: Commonly used in gene-expression regulation studies, neuronal cell-viability research models, and short-peptide bioregulator research applications.

Type
Short peptide bioregulator (tripeptide)
CAS Number
175175-23-2
Molecular Weight
418.40 g/mol
Formula
C15H26N6O8
Amino Acids
3
Sequence
Glu-Asp-Arg (EDR)
PubChem Database
Storage Requirements

Stability Information

Protect from lightTemperature-sensitive
Lyophilized (powder)-20°C · stable long-term
Reconstituted2-8°C · use within 28 days

Sources & References

Peer-reviewed research

Rejuvenation Research
Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes
2011PMID 21978084DOI 10.1089/rej.2011.1172
Khavinson V, Ribakova Y, Kulebiakin K, et al.
View on PubMed
Molecules
2020PMID 33396470DOI 10.3390/molecules26010159
Khavinson V, Linkova N, Kozhevnikova E, et al.
View on PubMed
Advances in Gerontology
[Investigation of antihypoxic properties of short peptides]
2008PMID 18546825
Kozina LS
View on PubMed

Some titles are not reproduced here. Ventra Sciences sells for research use only and does not republish therapeutic indications; open the record on PubMed to read the full citation.

References are provided for qualified researchers as a starting point for literature review. Ventra Sciences makes no claims about the contents of cited works.

For research use only

This product is intended strictly for in vitro laboratory research by qualified professionals. It is not for human or veterinary use and must not be used in food, drugs, diagnostics, or cosmetics. Ventra Sciences makes no medical claims regarding any compound sold. All purchasers acknowledge they will use this product solely for research purposes.

This compound has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. All use must comply with applicable institutional, local, and federal regulations.

By purchasing from Ventra Sciences, the buyer affirms they are a qualified researcher or institution. All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory compliance.

Subscribe to our newsletter

Exclusive updates and restock alerts, straight to your inbox.